Greenway Greenhouse CannabisGWAYF -21.58%27 PS Ratio is 1.63 as of Jul. 05, 2026, which is 72% below its 10-year median of 5.92. GuruFocus rates GWAYF with a GF Score™ of 27/100 and a GF Value™ of $0.23 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 949 Drug Manufacturers companies, Greenway Greenhouse Cannabis ranks better than 53.32% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Greenway Greenhouse Cannabis's share price is $0.07995.
Greenway Greenhouse Cannabis's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.05. Hence, Greenway Greenhouse Cannabis's PS Ratio for today is 1.63.
Good Sign:
Greenway Greenhouse Cannabis Corp stock PS Ratio (=2.03) is close to 5-year low of 2.03.
The historical rank and industry rank for Greenway Greenhouse Cannabis's PS Ratio or its related term are showing as below:
GWAYF'
s PS Ratio Range Over the Past 10 Years
Min: 2.03 Med: 5.92 Max: 132
Current: 2.03
During the past 5 years, Greenway Greenhouse Cannabis's highest PS Ratio was 132.00. The lowest was 2.03. And the median was 5.92.
GWAYF's PS Ratio is ranked better than 53.32% of 949
companies
in the Drug Manufacturers industry
Industry Median: 2.31
vs GWAYF: 2.03
During the past 5 years, Greenway Greenhouse Cannabis's highest 3-Year average Revenue per Share Growth Rate was 65.50% per year. The lowest was 65.50% per year. And the median was 65.50% per year.
Back to Basics: PS Ratio
Greenway Greenhouse Cannabis (OTCPK:GWAYF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Greenway Greenhouse Cannabis PS Ratio Related Terms
Greenway Greenhouse Cannabis PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Greenway Greenhouse Cannabis's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greenway Greenhouse Cannabis PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Greenway Greenhouse Cannabis's PS Ratio distribution charts can be found below:
* The bar in red indicates where Greenway Greenhouse Cannabis's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Greenway Greenhouse Cannabis's Share Price of today is $0.07995. Greenway Greenhouse Cannabis's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Greenway Greenhouse Cannabis (GWAYF) has a PS Ratio of 1.63 as of Jul. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Greenway Greenhouse Cannabis and its competitors. This is 72% below median its historical median of 5.92. Over the past decade, Greenway Greenhouse Cannabis' PS Ratio has ranged from 2.03 to 132.00. According to the industry distribution chart, Greenway Greenhouse Cannabis ranks #443 out of 949 companies in the Drug Manufacturers industry, placing it in the top 46.7%.
Is Greenway Greenhouse Cannabis' PS Ratio too high?
Greenway Greenhouse Cannabis' current PS Ratio of 1.63 is 72% below median its 10-year median of 5.92. Over the past 10 years, this metric has ranged from a low of 2.03 to a high of 132.00. The Drug Manufacturers industry median PS Ratio is 2.31. Greenway Greenhouse Cannabis' value of 1.63 is 29.4% below this industry median. Based on the distribution chart, Greenway Greenhouse Cannabis ranks #443 out of 949 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Greenway Greenhouse Cannabis has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Greenway Greenhouse Cannabis' PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Greenway Greenhouse Cannabis ranks #443 out of 949 companies for PS Ratio. This puts Greenway Greenhouse Cannabis in the upper half of its industry. The industry median PS Ratio is 2.31. Greenway Greenhouse Cannabis' value of 1.63 is 29.4% below this benchmark. Historically, Greenway Greenhouse Cannabis' own PS Ratio has ranged from 2.03 to 132.00 over the past decade. While the company's 10-year median is 5.92 vs. the industry median of 2.31, Greenway Greenhouse Cannabis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.31, based on 949 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Greenway Greenhouse Cannabis's current PS Ratio of 1.63 is 29.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Greenway Greenhouse Cannabis and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Greenway Greenhouse Cannabis's current PS Ratio is 1.63, which is 72% below median its own 10-year median of 5.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenway Greenhouse Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis (GWAYF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.23, compared to a current price of $0.08 — trading 65.2% below its estimated fair value. The current PS Ratio is 1.63, which is 72% below median its 10-year median of 5.92 and 29.4% below the Drug Manufacturers industry median of 2.31. Greenway Greenhouse Cannabis' overall GF Score™ is 27/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Greenway Greenhouse Cannabis (GWAYF), the current PS Ratio is 1.63 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Greenway Greenhouse Cannabis (GWAYF) Overvalued in 2026?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis stock appears to be undervalued.
The current stock price of $0.08 is trading 65.2% below its estimated GF Value™ of $0.23.
GuruFocus considers Greenway Greenhouse Cannabis to be Possible Value Trap.
Key valuation signals for GWAYF:
PS Ratio: 1.63 (72% below median its 10-year median of 5.92)
GF Value™: $0.23 vs. price of $0.08 (65.2% below fair value)
Industry Position: 29.4% below the Drug Manufacturers median (#443 of 949)
No single metric tells the full story. See the GWAYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Greenway Greenhouse Cannabis Corp is licensed to cultivate, process and sell to ensures harvests always consist of the highest quality cannabis strains with resinous flowers, trichomes, and rich cannabinoid profiles. The Company's nursery facility is located in Kingsville, Ontario, and its flowering and processing facility is located in Leamington, Ontario. The business model is to supply bulk packaged, high quality cannabis to the Canadian, cannabis industry at prices that ultimately provide a value proposition to the consumers. Greenway has three divisions with various locations; Greenway Nursery, Greenway Cultivation and future plans for Greenway Farmgate Retail Store.
27GF Score
Get the complete analysis for GWAYF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GWAYF has been successfully added to your 
